Dyer et al. (this issue) assess the risk of new basal cell carcinoma (BCC) in the Veterans Affairs topical tretinoin chemoprevention trial, which included individuals with a history of at least two prior keratinocyte carcinomas. In addition to known risk factors for a future BCC, such as number of prior BCCs, a history of eczema and lower education levels were also associated with greater risk.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/jid.2012.323 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!